1. 125 Results of a randomized phase ii trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent chemonaive stromal ovarian tumors. (13th November 2020) Authors: Brown, J; Miller, A; Moxley, K; Backes, F; Nagel, C; Bender, D; Miller, D; Powell, M; Westin, S; Bonebrake, A; Muller, C; Alvarez Secord, A; Crane, E; Schorge, J; Tew, W; Sood, A; Aghajanian, C Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial. (13th November 2020) Authors: Freyer, G; Pothuri, B; Han, S; Chase, D; Monk, B; Heitz, F; Burger, R; Gaba, L; Van Le, L; Guerra, E; Bender, D; Korach, J; Cloven, N; Churruca, C; Follana, P; DiSilvestro, P; Baurain, JF; Jardon, K; Pisano, C; Peen, U Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗